Reckitt to pay $1.4 billion to end Indivior probe
11 Jul 2019
Britain’s Reckitt Benckiser will pay up to $1.4 billion to resolve all US federal investigations into the sales and marketing of an opioid addiction treatment by its former prescription pharmaceuticals